Abstracts of the XII Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 12)

Le résumé fourni par la source

The XII Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 12), organized by the Spanish Group for Cancer Immuno-Biotherapies (GÉTICA), took place on 5–6 March 2026 in Málaga, Spain. This edition gathered clinicians, basic scientists, and translational researchers from Spain and international institutions to discuss the latest advances in cancer immunotherapy. Scientific contributions spanned a wide range of topics, including engineered T-cell therapies targeting solid tumors and hematological malignancies, neoantigen-based cancer vaccines in preventive and therapeutic settings, oncolytic virotherapy combined with immune cell recruitment strategies, metabolic reprogramming of the tumor microenvironment, epigenetic liquid biopsy biomarkers, and the management of immune-related adverse events in clinical practice. The abstracts presented here reflect the breadth and translational depth of immuno-oncology research currently underway within the GÉTICA network and its international collaborators.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.